Literature DB >> 23945913

Stepped care: an alternative to routine extended treatment for patients with borderline personality disorder.

Joel Paris.   

Abstract

This review examined evidence supporting stepped care for borderline personality disorder as an alternative to routine extended treatment. Empirical studies have shown that patients with borderline personality disorder have a heterogeneous course, but symptomatic improvement can sometimes be relatively rapid. Currently, there is no evidence that any long-term treatment is superior to briefer interventions for borderline personality disorder. Long-term therapy may not be necessary for all patients, and its routine use leads to access problems. A stepped-care model, similar to models applied to other severe mental disorders, might provide a better use of resources. Stepped care can be used to limit the use of expensive programs and reduce waiting lists. Not all patients with borderline personality disorder can be treated briefly, but a stepped-care model allows those with less severe symptoms to be managed with fewer resources, freeing up more time and personnel for the treatment of those who need treatment the most.

Entities:  

Mesh:

Year:  2013        PMID: 23945913     DOI: 10.1176/appi.ps.201200451

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  15 in total

Review 1.  The Psychiatrist as Clinical Behavioural Scientist.

Authors:  Richard Hibbard
Journal:  Can J Psychiatry       Date:  2017-04-03       Impact factor: 4.356

Review 2.  Diagnosis and Treatment of Borderline Personality Disorder in the College Mental Health Setting.

Authors:  Claire M Brickell
Journal:  Curr Psychiatry Rep       Date:  2018-05-18       Impact factor: 5.285

3.  Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study.

Authors:  Fernando Lana; Carmen Sánchez-Gil; Núria D Adroher; Víctor Pérez; Guillem Feixas; Josep Martí-Bonany; Marta Torrens
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-21       Impact factor: 2.570

Review 4.  Future directions in personality pathology development research from a trainee perspective: Suggestions for theory, methodology, and practice.

Authors:  Benjamin N Johnson; Salome Vanwoerden
Journal:  Curr Opin Psychol       Date:  2020-08-20

5.  Treatment of personality disorder using a whole of service stepped care approach: A cluster randomized controlled trial.

Authors:  Brin F S Grenyer; Kate L Lewis; Mahnaz Fanaian; Beth Kotze
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

Review 6.  Recent developments in psychosocial interventions for borderline personality disorder.

Authors:  Christina M Temes; Mary C Zanarini
Journal:  F1000Res       Date:  2019-04-26

7.  Statistical design and analysis in trials of proportionate interventions: a systematic review.

Authors:  Jane Candlish; M Dawn Teare; Judith Cohen; Tracey Bywater
Journal:  Trials       Date:  2019-02-28       Impact factor: 2.279

8.  Evaluation of a brief intervention within a stepped care whole of service model for personality disorder.

Authors:  Elizabeth Huxley; Kate L Lewis; Adam D Coates; Wayne M Borg; Caitlin E Miller; Michelle L Townsend; Brin F S Grenyer
Journal:  BMC Psychiatry       Date:  2019-11-06       Impact factor: 3.630

9.  Effects of substance use disorder on treatment process and outcome in a ten-session psychiatric treatment for borderline personality disorder.

Authors:  Louise Penzenstadler; Stéphane Kolly; Stéphane Rothen; Yasser Khazaal; Ueli Kramer
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-02-26

10.  Psychological Support for Personality (PSP) versus treatment as usual: study protocol for a feasibility randomized controlled trial of a low intensity intervention for people with personality disorder.

Authors:  Mike J Crawford; Lavanya Thana; Jennie Parker; Oliver Turner; Kwek Pei Xing; Mary McMurran; Paul Moran; Timothy Weaver; Barbara Barrett; Amy Claringbold; Paul Bassett; Rahil Sanatinia
Journal:  Trials       Date:  2018-10-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.